2007
DOI: 10.1128/cvi.00368-06
|View full text |Cite
|
Sign up to set email alerts
|

Galactoxylomannan Does Not Exhibit Cross-Reactivity in the PlateliaAspergillusEnzyme Immunoassay

Abstract: Given the recent report of a false-positive result in the Platelia Aspergillus enzyme immunoassay in a patient with cryptococcosis and in yeast extracts and purified galactoxylomannan of Cryptococcus neoformans, we evaluated culture extracts, purified polysaccharides, clinical specimens, and specimens from animals following experimental infection. Our results revealed no cross-reactions.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
11
2

Year Published

2007
2007
2019
2019

Publication Types

Select...
9
1

Relationship

3
7

Authors

Journals

citations
Cited by 17 publications
(13 citation statements)
references
References 13 publications
0
11
2
Order By: Relevance
“…The C. neoformans cell wall contains galactoxylomannan, an antigen similar to galactomannan, which may result in a cross-reaction in the galactomannan test (2). However, this was not confirmed in a recent study (3). The hypothesis that genotypic variations could explain the differences observed among studies with C. neoformans remains to be tested.…”
contrasting
confidence: 44%
“…The C. neoformans cell wall contains galactoxylomannan, an antigen similar to galactomannan, which may result in a cross-reaction in the galactomannan test (2). However, this was not confirmed in a recent study (3). The hypothesis that genotypic variations could explain the differences observed among studies with C. neoformans remains to be tested.…”
contrasting
confidence: 44%
“…Alternatively, this finding may be caused by C. neoformans galactoxylomannan, which cross-reacts with the Aspergillus GM antigen assay (4). However, the cross-reactivity was not confirmed in a recent comprehensive study (5). Since determination of serum cryptococcal antigen levels using a latex agglutination test is sensitive and specific for immunocompromised hosts, it will not hamper the usefulness of the GM antigen assay in the diagnosis of invasive fungal infections in HIV-infected patients.…”
Section: Discussionmentioning
confidence: 99%
“…Given this structural variability, it is possible that GalXM made in vivo is structurally different from that made in culture. In fact, it is conceivable that interstrain and growthrelated differences in GalXM structure are responsible for discrepant results observed regarding serological cross-reactivity of the polysaccharide with other antigens (7,8). Given that GalXM has now been associated with profound immunological derangements (26,27,30), it is likely that this polysaccharide makes a contribution to the virulence composition of C. neoformans (9,20,23).…”
mentioning
confidence: 96%